Publications by authors named "Anouk Widmer"

Claim this Profile
I
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial.
Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stüssi, Anouk Widmer

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Moritz Fürstenau, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie van der Kevie-Kersemaekers, Anouk Widmer

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Barbara Eichhorst, Carsten U Niemann, Arnon P Kater, Moritz Fürstenau, Julia von Tresckow, Anouk Widmer

N Engl J Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia.
Anouk Widmer, André Z Linka, Christine H Attenhofer Jost, Barbara Buergi, Hans Peter Brunner-La Rocca

Cardiology· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis